Evaluation of contrast-enhanced color doppler ultrasound for the quantification of angiogenesis in vivo

Investigative Radiology

Volumn 36, Issue 1, 2001, Pages 50-55

  Lassau, Nathalie ^a   Koscielny, Serge ^a   Opolon, Paule ^a   De Baere, Thierry ^a   Peronneau, Pierre ^b   Leclere, Jérôme ^a   Roche, Alain ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CNRS   (France)

Author keywords

Angiogenesis; Color Doppler ultrasonography; Contrast agent; Tumor

Indexed keywords

CONTRAST MEDIUM; SHU 508;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON TUMOR; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HISTOPATHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 0035154352     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200101000-00007     Document Type: Article

References (17)

1. Tumor angiogenesis: Therapeutic implications
2. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
3. New perspectives in clinical oncology from angiogenesis research
4. New hemodynamic approach to angiogenesis: Color and pulsed Doppler ultrasonography
5. Prognostic value of highfrequency sonography and color Doppler US for the pre-operative assessment of melanomas
6. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: Preliminary experience
7. Use of a permanent cell line extract to study the tumor associated immune reactions in colorectal cancer patients by leucocyte migration inhibition test
8. Radio-frequency ablation of hepatic metastases: Postprocedural assessment with a US microbubble contrast agent: Early experience
9. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
10. New prospects for ultrasound contrast agents
11. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: Early experience in seven patients with metastases
12. Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US: Early experience
13. Contrast enhancing agents in ultrasonography: Clinical applications
14. Detection of tumor angiogenesis in vivo by αVβ3-targeted magnetic resonance imaging
15. Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent
16. Assessment of the vascularization of neuroendocrine tumors by stimulated acoustic emission of SHU 508A ultrasound contrast agent and color or intensity Doppler sonography
17. First experiences in using a new ultrasound mode and ultrasound contrast agent in the diagnosis of blunt renal trauma: A feasibility study in an animal model